Structure and Folding of Nascent Polypeptide Chains during Protein Translocation in the Endoplasmic Reticulum*

(Received for publication, February 12, 1997, and in revised form, March 29, 1997)

Robin L. Haynes Dagger , Tianli Zheng and Christopher V. Nicchitta §

From the Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

To investigate the role of protein folding and chaperone-nascent chain interactions in translocation across the endoplasmic reticulum membrane, the translocation of wild type and mutant forms of preprolactin were studied in vivo and in vitro. The preprolactin mutant studied contains an 18-amino acid substitution at the amino terminus of the mature protein, eliminating a disulfide-bonded loop domain. In COS-7 cells, mutant prolactin accumulated in the endoplasmic reticulum as stable protein-protein and disulfide-bonded aggregates, whereas wild type prolactin was efficiently secreted. In vitro, wild type and mutant preprolactin translocated with equal efficiency although both translation products were recovered as heterogeneous aggregates. Studies with translocation intermediates indicated that aggregation occurred co-translationally. To evaluate the contribution of lumenal chaperones to translocation and folding, in vitro studies were performed with native and reconstituted, chaperone-deficient membranes. The absence of lumenal chaperones was associated with a decrease in translocation efficiency and pronounced aggregation of the translation products. These studies suggest that chaperone-nascent chain interactions significantly enhance translocation and indicate that in the absence of such interactions, aggregation can serve as the predominant in vitro protein folding end point. The ramifications of these observations on investigations into the mechanism of translocation are discussed.


INTRODUCTION

Current models of protein translocation across the mammalian endoplasmic reticulum (ER)1 depict translocation as a process in which vectorial transport accompanies formation of a tight junctional complex between the ribosome and the protein conducting channel with the free energy for translocation provided by passive diffusion (1, 2). In alternative models, vectorial transport may also be driven through interaction of the nascent chain with lumenal molecular chaperones (3-6), as well as structural modifications of the nascent chain, i.e. protein folding, disulfide bond formation and, in many cases, addition of N-linked oligosaccharides, that occur coincident with translocation (7-11). In the latter model, interactions between the nascent chain and lumenal molecular chaperones are thought to prevent retrograde transport through the translocation pore and thus bias movement of the nascent chain into the lumenal compartment (3-6, 12).

Recent reconstitution experiments have identified the minimum subset of ER proteins necessary for in vitro protein translocation in the mammalian ER (13, 14). In the minimal system, the translocation machinery is comprised of the signal recognition particle receptor which functions in the targeting of ribosome/nascent chain complexes to the ER, the Sec61p complex, which is thought to serve as a ribosome receptor and translocation channel, and, in some instances, the integral membrane protein TRAM, which participates in signal sequence recognition (13-15). The identification of the Sec61p complex as the primary ribosome receptor and translocation channel suggests that ribosome association with Sec61p could provide the aqueous pathway for nascent chain transit into the lumen (15, 16).

It is clear from molecular genetic and biochemical studies that hsp70 proteins perform an essential function in protein translocation across the yeast ER and the mitochondrial inner membrane (17-22). From these studies, it has been proposed that hsp70 proteins promote unidirectional transport by binding to the nascent chain as it emerges into the lumen (matrix). It has not yet been established whether the interaction of the hsp70 proteins with the nascent chain drives vectorial transport by a thermal ratchet mechanism (3-5), or, alternatively, by a conformationally driven, motor process (23, 24). Furthermore, there is disagreement as to whether the role of hsp70 proteins is limited to translocation events that occur post-translationally (20), or alternatively, whether hsp70 proteins are required for co- and post-translational translocation (25). Interestingly, it has been demonstrated that BiP is necessary for the complete translocation of prepro-alpha -factor, a precursor known to translocate post-translationally (26). In the absence of BiP function, pro-alpha -factor is unable to fully transit to the ER lumen (26). This defect, referred to as stalling, is quite similar to a translocation defect observed in mammalian microsomes that have been depleted of their lumenal contents (5). In mammalian microsomes, the loss of lumenal proteins causes a disruption of the translocation reaction at a point subsequent to signal sequence cleavage, and results in the accumulation of the signal-cleaved nascent chains that are unable to efficiently transit to the vesicle lumen (5).

The analysis of the energetics of protein translocation is made difficult by the fact that protein translation, translocation, and folding are coincident processes and furthermore, that protein folding occurs in an environment, the ER lumen, which is highly enriched in molecular chaperones and protein folding enzymes. To study the contribution of protein folding and lumenal chaperone-nascent chain interactions to translocation, the translocation behavior of wild type and mutant forms of preprolactin (pPL) were analyzed in vivo and in vitro. The mutant preprolactin used in this study contains an 18-amino acid substitution at the NH2 terminus of the mature protein, eliminating a small disulfide-bonded loop domain (27, 28). Whereas wild type (WT) prolactin was efficiently secreted in vivo, the folding mutant (FA) accumulated in the ER as large protein-protein and disulfide-bonded aggregates. In vitro, both WT and FA forms of prolactin were translocated with similar efficiencies but were recovered as mixed aggregates. Furthermore, aggregation was apparent co-translationally. In the absence of lumenal chaperones, aggregate formation was markedly enhanced and was accompanied by a reduction in translocation efficiency. On the basis of these data, we propose that lumenal protein-nascent chain interactions are paramount to efficient translocation and in their absence, irreversible protein-protein aggregation may serve as the predominant protein folding end point.


MATERIALS AND METHODS

Cell Culture/Transfection

COS-7 cells (29) were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 µg/ml streptomycin. Transfections were performed by the DEAE-dextran method, as described in Ref. 30.

Clones and Vectors

Clone pPC-BP1 was constructed by excision of a full-length bovine preprolactin cDNA from the plasmid pGEMBP1 (31) with HindIII and EcoRI, and subcloning of the HindIII/EcoRI fragment into HindIII/EcoRI-digested mammalian expression vector pCDNA3 (Invitrogen, La Jolla, CA).

Mutant clone pPL-FA was constructed by 5' add-on/recombinant PCR (32) using pGEMBP1 as template. In the mutant clone FA, the first 18 amino acids of mature prolactin are: YHCDGFQNEQIYTDLEMN, whereas in wild type prolactin, the sequence is: TPVCPNGPGNCQVSLNDL. In wild type prolactin, a disulfide bond is formed between amino acids 4 and 11 (28). In the mutant the entire disulfide-bonded loop domain has been exchanged with a random sequence.

In the first series of PCR reactions, two products were synthesized using the following oligonucleotides: product 1, sense, 5'-TGGCAGACTCTAGAGCATGGACAG-3' and antisense, 5'-ATAAATTTGCTCGTTCTGAAACCATCACAATGATAGGAGACCACACCCTG-3'; product 2, sense, 5'-AACGAGCAAATTTATACTGATTTGGAGATGAACTTTGACCGGGCAGTC-3' and antisense, 5'-GCCGAATTCTTAGCGTTGTTGTT-3'.

Products 1 and 2 were gel purified and used as template cDNA in a second PCR reaction with oligonucleotides product 1, sense, and product 2, antisense. PCR was performed as described above and the product, representing full-length pPL-FA cDNA, gel purified. Full-length pPL-FA cDNA was digested with HindIII/BamHI and subcloned into the vector pCDNA3 for transient transfection experiments. Positive clones, identified by antibiotic selection and restriction mapping, were subjected to dideoxy sequencing prior to transfection studies, to ensure the accuracy of the mutations.

Pulse-Chase/Immunoprecipitation

Pulse-chase studies were performed 40-48 h post-transfection as described in Ref. 33. Monolayer cultures in 60-mm dishes were washed twice in methionine and cysteine-free Dulbecco's modified Eagle's medium and the respective cellular amino acid pools depleted by incubation in methionine and cysteine-free Dulbecco's modified Eagle's medium for 20 min at 37 °C. The labeling reaction was subsequently performed by addition of 200 µCi/ml [35S]methionine/cysteine (Pro-Mix; Amersham) in 300 µl of methionine/cysteine-free Dulbecco's modified Eagle's medium for 15 min at 37 °C. Following the labeling period, isotope-supplemented media was removed, and cells washed in complete Dulbecco's modified Eagle's medium containing 2 mM methionine, 0.5 mM cysteine, 1% fetal calf serum (chase media). At the indicated time points, the chase media (0.5 ml) was removed and the cells harvested by scraping into ice-cold PBS. Cells were washed 2 times in PBS and lysed by addition of 1 ml of lysis buffer (25 mM Tris/Cl (pH 7.4), 300 mM NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, 25 µg/ml soybean trypsin inhibitor, 5 mM EDTA). After a brief sonication, samples were supplemented with bovine serum albumin, to a final concentration of 2.5 mg/ml, and centrifuged to remove particulate material. Lysates were pre-cleared by addition of either 40 µl of a 50% slurry of Protein A-Sepharose or the equivalent volume of Pansorbin (Calbiochem) and indirect immunoprecipitations performed by addition of rabbit anti-sheep prolactin (U. S. Biochemical Corp., Cleveland, OH) (1:250 dilution) and overnight incubation at 4 °C. Immune complexes were collected by addition of 40 µl of a 50% slurry of Protein A-Sepharose and incubation at room temperature for 30 min. Protein A-Sepharose resin was collected by centrifugation (2 min, 2,000 × g), extensively washed with lysis buffer, and resuspended in PBS. Radiolabeled prolactin was eluted by addition of 40 µl of 0.5 M Tris, 5% SDS, 0.1 M DTT and heating for 20 min at 65 °C and 5 min at 95 °C. Samples were resolved on 12.5% SDS-PAGE gels or Tris-Tricine gels as described previously (34). In experiments in which disulfide bond formation was studied, monolayers were washed in ice-cold PBS, and prior to lysis, free sulfhydryls alkylated by addition of 20 mM N-ethylmaleimide (NEM) for 20 min on ice, as described in Ref. 35.

Isolation and Protease Digestion of COS-7 Microsomal Fraction

Microsomal membranes from transfected COS-7 cells were prepared as follows: 40 h post-transfection, cells from two 100-mm culture dishes were pulse labeled as described above, the labeling media removed, and the cells recovered by scraping into ice-cold hypotonic lysis buffer (10 mM K-HEPES, pH 7.4, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml pepstatin). The cells were washed 1 time in lysis buffer, resuspended to 1 ml, incubated on ice for 15 min, and homogenized (20 strokes) with a tight fitting Dounce homogenizer. The homogenate was adjusted to 250 mM sucrose and centrifuged for 10 min at 700 × g (4 °C). The supernatant from this step was removed and the centrifugation step repeated. The final supernatant was centrifuged for 15 min at 70,000 rpm in the Beckman TLA100.3 rotor. The resulting pellet fraction, representing the post-nuclear membranes, was resuspended in 250 mM sucrose, 10 mM K-HEPES (pH 7.2), 50 mM KCl, 2 mM MgCl2, 2 mM CaCl2, to a final volume of 0.5 ml. Protease digestions were performed on ice for 30 min with 50 µg/ml proteinase K. Where indicated, Triton X-100 was present at 0.5%. Protease digestions were quenched by addition of phenylmethylsulfonyl fluoride to 3 mM and after a 15-min incubation on ice, the membranes were solubilized with lysis buffer, and radiolabeled prolactin translation products isolated by immunoprecipitation.

Analysis of Aggregation State

Pulse-chase studies were performed as described above and incubations quenched by addition of ice-cold PBS supplemented with 20 mM NEM. Cell lysates were prepared as described (35) and cleared of large aggregates by centrifugation for 15 min at 15,000 × g (4 °C). Lysates were overlaid onto 8-35% sucrose gradients prepared in lysis buffer supplemented with 0.2% Triton X-100. Gradients were prepared and harvested with a Buchler Auto-Densi Flow apparatus (Buchler Instruments, Lexana, KY). Gradients were centrifuged for 16 h at 39,000 × rpm in the Beckman SW-40 rotor (4 °C). 850-µl fractions were collected, and indirect prolactin immunoprecipitations performed as described above.

Protein Translation/Translocation

In vitro protein translation/translocation experiments were performed as described in Ref. 36. All translations were performed using reticulocyte lysate, prepared as in Ref. 37, and canine pancreas rough microsomes, prepared as described in Ref. 38.

Membrane Reconstitution

Reconstitution of translocation competent membranes from detergent-solubilized canine pancreas rough microsomes was performed as described in Ref. 39.


RESULTS

Generation of Preprolactin Structural Mutant FA

The preprolactins are members of a family of hormones that include the growth hormones and placental lactogens (27, 28). These proteins share extensive amino acid sequence homology and are thought to display a conserved, general, three-dimensional structure (27, 40). The mammalian prolactins can be readily distinguished from the growth hormones by a small, disulfide-bonded loop (amino acid residues 4-11) present at the amino terminus (27, 28). The disulfide-bonded loop immediately precedes one of the four alpha -helical segments characteristic of this family of hormones and is diagramatically illustrated in Fig. 1. By PCR mutagenesis, the sequence encompassing this disulfide-bonded domain was exchanged with a random amino acid sequence, lacking the residues 4-11 disulfide bond pair, to yield a mutant referred to as pPL-FA (Fig. 1).


Fig. 1. Structural model of prolactin: localization of the mutant disulfide-bonded loop domain. A structural model of prolactin was developed using the molecular coordinate data base for growth hormone, a prolactin homolog. The molecular coordinates were obtained from the Brookhaven National Laboratories Protein Data Bank and the ribbon model developed using the RASMol (V2.6) molecular graphics program (63) obtained at http://hydrogen.cchem.berkeley.edu:8080/Rasmol/. The amino acid sequence of the wild type and mutant sequence are illustrated, as is the location of the four prominent alpha -helical domains and the NH2-terminal disulfide bond present in the mature, folded protein.
[View Larger Version of this Image (15K GIF file)]

It has been established that disulfide bond formation can occur immediately upon the appearance of a relevant cysteine-cysteine pair in the ER lumen (41). In the prolactin mutant FA, the NH2-terminal domain lacks the cysteine pair present in the wild type protein, and therefore a protein folding event which likely occurs very early in translocation, perhaps immediately upon access of the nascent chain to the ER lumen, cannot occur. It was postulated that mutations within this discrete structural domain would significantly disrupt the protein folding pathway of prolactin, and thereby prove useful in investigations on the contributions of protein folding and lumenal protein interactions to protein translocation.

FA Is Neither Secreted Nor Degraded

Exit of secretory proteins from the ER occurs coincident with structural maturation and is the underlying basis for the variations in the rate of secretion observed between proteins in a given cell (42-45). To assay for disruptions in the folding behavior of pPL-FA, pulse-chase studies were performed in transfected COS-7 cells expressing either pPL-WT or pPL-FA. The results of these studies are depicted in Fig. 2. Under the described conditions, prolactin-WT is rapidly secreted with a half-time of 25 min (n = 4) (Fig. 2A, WT). Prolactin-FA, in contrast, remained predominately cell associated throughout the 90-min chase time (Fig. 2A, FA), indicating that prolactin-FA displays a significant defect in protein folding.


Fig. 2. Kinetics of secretion: wild type and mutant prolactin. Forty hours post-transfection, COS-7 cells were pulse labeled with [35S]methionine (200 µCi/ml) for 15 min at 37 °C. Subsequently, the labeling media was exchanged with isotope-free media, supplemented with 2 mM L-methionine, and at the indicated time points the media was removed and the cells lysed in immunoprecipitation buffer. Radiolabeled prolactin was recovered from the media and lysed cell extracts by indirect immunoprecipitation, as described under "Materials and Methods." The immunoprecipitates were reduced, separated by SDS-PAGE on 12.5% gels, and analyzed by PhosphorImaging. A digital image of the gel is depicted. A, kinetics of secretion 0-90 min time course. B, kinetics of secretion, 0-8 h time course. WT, wild type prolactin; FA, mutant prolactin; C, cells; and M, media.
[View Larger Version of this Image (78K GIF file)]

Proteolytic degradation via a non-lysosomal protein degradation pathway is a common fate of transport-incompetent proteins (46, 47). To assess the stability of the secretion incompetent prolactin-FA, extended pulse-chase studies were performed. In these experiments, it was observed that at chase periods of up to 8 h, the vast majority of the prolactin-FA was neither secreted nor degraded (Fig. 2B, compare WT versus FA). These results suggest that prolactin-FA is either not a substrate for the relevant proteases or, alternatively, has not gained access to the degradation compartment.

FA Is Retained in a Membrane Compartment

Recent studies on ER-associated protein degradation have provided evidence of a novel pathway which functions to transport malfolded proteins from the ER to the cytosol, for subsequent degradation by the proteasome complex (48-50). To determine if prolactin-FA was retained within a membrane compartment, presumably the ER, nascent chains were pulse-labeled and a microsomal fraction prepared from the labeled cells. The protease accessibility of prolactin-FA and prolactin-WT in the microsomal fraction was then ascertained by digestion with exogenous proteases. The results of these experiments are shown in Fig. 3. Both WT and FA forms of prolactin were equivalently protected from digestion with exogenous proteases in the absence (lanes 2 and 5) but not the presence (lanes 3 and 6) of detergent. The absolute degree of protease protection varied from 40 to 70% between experiments although in all cases the relative degree of protease protection of prolactin-WT and prolactin-FA was nearly identical.2 These data, in combination with those presented in Fig. 2, indicate that the described mutation in the NH2-terminal disulfide-bonded loop domain yields a form of prolactin that is efficiently translocated yet remains in a structural state that is unsuitable for transport through the secretory pathway or retrograde transport to the cytosol.


Fig. 3. Wild type and mutant forms of preprolactin are translocated in vivo. COS-7 cells, transfected with either WT or FA forms of pPL, were pulse labeled with [35S]methionine, as described in the legend to Fig. 2, and a post-nuclear membrane fraction isolated as described under "Materials and Methods." Where indicated, aliquots of the post-nuclear membrane fraction were digested for 30 min on ice with 50 µg/ml proteinase K, in the presence or absence of 0.5% Triton X-100. Reactions were quenched by addition of phenylmethylsulfonyl fluoride to 0.5 mM and radiolabeled prolactin recovered by indirect immunoprecipitation.
[View Larger Version of this Image (34K GIF file)]

FA Forms Protein-Protein and Disulfide-bonded Aggregates

It has been reported that nascent chains may form protein-protein, as well as disulfide-bonded aggregates, during protein folding in the ER (44, 45, 51). To assess the structural status of translocated WT and FA forms of prolactin, transfected cells were metabolically labeled, chilled, treated with 20 mM NEM to block artifactual disulfide bond formation (35), and detergent lysates prepared for analysis by velocity sedimentation (Fig. 4A). In cells expressing prolactin-FA, metabolic labeling was performed in the presence (FA + DTT), or absence (FA - DTT) of 20 mM DTT. It has previously been demonstrated that in the presence of DTT, disulfide bond formation in the ER is blocked, in many cases leading to a reversible disruption in protein folding (35, 44). Following centrifugation and harvesting of the gradients, prolactin was recovered by immunoprecipitation and analyzed by SDS-PAGE. As shown in Fig. 4A, prolactin-WT was recovered at the top of the gradient, consistent with a monomeric status for the export competent protein. In contrast, prolactin-FA was present as heterogeneous aggregates, widely dispersed through the gradient fractions and displaying sedimentation coefficients of 10-40 S (Fig. 4A; data not shown). The relative distribution of FA was unaffected when labeling was performed under reducing conditions, indicating that protein-protein interactions contribute substantially to aggregate formation. These results clearly indicate that the structural state of the mutant prolactin differs markedly from the wild type. In further studies, in which cells were treated with cross-linking reagents prior to lysis, the ER chaperone BiP was identified in the FA aggregate pool.2 The use of cross-linking reagents was, however, necessary to identify such interactions.


Fig. 4. Prolactin-FA undergoes extensive protein-protein and disulfide bond mediated aggregation in vivo. A, COS-7 cells were transfected with wild type (WT) and mutant (FA) forms of pPL. Forty hours post-transfection, cells were pulse labeled as described in the legend to Fig. 2. Where indicated, pulse labeling was performed in the presence of DTT. Following metabolic labeling, cells were washed, chilled on ice, and treated with 20 mM NEM to block artifactual disulfide bond formation. Cell lysates were prepared, cleared of large aggregates by centrifugation for 15 min at 15,000 × g, and overlaid onto 8-35% sucrose gradients supplemented with 0.2% Triton X-100. Gradients were centrifuged for 16 h at 39,000 × rpm in the Beckman SW-40 rotor (4 °C). Fractions were collected, indirect prolactin immunoprecipitations performed, and the immunoprecipitates analyzed by SDS-PAGE and PhosphorImaging. Digital images of the gels are depicted. B, COS-7 cells were transfected with wild type and mutant forms of pPL. Forty hours post-transfection, cells were pulse labeled as described in the legend to Fig. 2, washed, and the chase period initiated. At the indicated time points, cells were lysed, and the radiolabeled prolactin recovered by indirect immunoprecipitation. Immunoprecipitates were split into two equivalent aliquots and solubilized for SDS-PAGE in either the presence or absence of 100 mM DTT. Samples were resolved by SDS-PAGE; a digital image derived from PhosphorImager analysis of the gel is depicted. The boundary between the separating and stacking gel is shown to the left. The location of mature prolactin is indicated by the asterisk.
[View Larger Version of this Image (57K GIF file)]

As prolactin-FA lacks the cysteine pair necessary for formation of the disulfide-bonded NH2-terminal loop, we postulated that protein folding would necessarily be disrupted at the level of disulfide bond formation. To ascertain the state of disulfide bond formation, WT and FA transformants were subjected to a pulse-chase study, and the cell-associated prolactin recovered at 0, 30, and 60 min. Following immunoprecipitation, samples were run on reducing and non-reducing gels. Disulfide bond formation stabilizes protein 3° protein structure, resulting in faster migration of the oxidized proteins on SDS-PAGE (35). This phenomenon was clearly evident with respect to WT-prolactin, in which oxidized prolactin was observed to migrate faster than reduced prolactin on SDS-PAGE gels (Fig. 4B, lanes 1-3 versus lanes 7-9). Prolactin-FA rapidly formed large disulfide-bonded aggregates and, under non-reducing conditions, was preferentially recovered in the stacking gel and stacking gel interface (Fig. 4B, lanes 4-6 versus lanes 10-12). In these experiments, large, disulfide-bonded prolactin-FA aggregates was observed at the zero time point (15-min labeling period), indicating that the formation of disulfide-bonded aggregates was quite rapid.

Translocation Behavior of pPL-WT and pPL-FA in Vitro

In vitro translocation systems have proven valuable in the identification and analysis of the molecular stages of translocation (5, 31, 36, 52). Having defined the structural basis of the in vivo secretion defect observed with prolactin-FA, the translocation and folding behavior of prolactin-WT and prolactin-FA were investigated in vitro using both native rough microsomes and reconstituted vesicles lacking lumenal proteins.

Depicted in Fig. 5, are the results of an in vitro translocation study of the WT and FA forms of pPL. In vitro, secretory protein translocation is commonly assessed by two criteria, signal sequence cleavage and insensitivity of the mature protein to digestion by exogenous proteases. By these criteria, pPL-FA behaves identically to pPL-WT. Thus, when translated in the presence of rough microsomes, both forms are subject to signal sequence cleavage (Fig. 5A, lanes 1, 2, and 4) and mature prolactin, but not the precursor, are protected from digestion with exogenous proteases (Fig. 5A, lanes 3 and 5). Clearly, both in vivo and in vitro, the protein folding defect associated with prolactin-FA was without effect on translocation.


Fig. 5. Translocation activity and structural state of preprolactin-WT and preprolactin-FA in vitro. A, mRNAs encoding either wild type or mutant preprolactin were translated for 30 min at 25 °C in a reticulocyte translation system in the presence or absence of canine pancreas rough microsomes (RM). After translation, and where indicated (lanes 3 and 5), proteinase K was added to a final concentration of 100 µg/ml and digestions performed for 30 min on ice. Samples were processed as described under "Materials and Methods" and separated on SDS-PAGE gels. A digital image of the gel, obtained by PhosphorImager analysis, is depicted. p, precursor form; m, mature, signal cleaved form. B, WT and FA forms of pPl were synthesized in vitro in the presence of canine pancreas rough microsomes. Following translation, reactions were treated with 20 mM NEM and the membrane fraction recovered by centrifugation through a 0.5 M sucrose cushion. The membrane fractions were solubilized in detergent, briefly centrifuged to remove insoluble components, and the supernatants centrifuged on 8-35% sucrose gradients. Gradient fractions were concentrated by trichloroacetic acid precipitation and separated on 12.5% SDS-PAGE gels. Digital images of the dried gels are depicted. WT, wild type preprolactin; FA, mutant preprolactin. C, quantitation of gradient distribution. Gels were quantitated by PhosphorImager analysis; a plot of translation product distribution (PhosphorImager PSL units) versus fraction number is shown.
[View Larger Version of this Image (45K GIF file)]

To determine the structural state of the in vitro translocated WT- and FA-prolactin, completed translocation reactions were treated with NEM, solubilized, and the structural status of the nascent chains analyzed by velocity sedimentation. In contrast to the in vivo results (Fig. 4A), in which the WT-prolactin was recovered in a fully folded, monomeric state, both WT- and FA-prolactin formed large, heterogeneous aggregates in vitro (Fig. 5B). Aggregate formation was more pronounced for prolactin-FA, with the majority of the protein sedimenting as large (>20 S) particles (Fig. 5B; data not shown). A quantitative depiction of the data is shown in Fig. 5C. It is apparent from comparison of Figs. 4B and 5C that the folding defect seen for FA-prolactin in vivo can be recapitulated in vitro. It is also evident from this comparison that the efficiency of WT-prolactin folding is significantly and substantially reduced in the in vitro translation/translocation system.

Co-translational Aggregation of Translocation Intermediates

The observation that WT-prolactin undergoes substantial aggregation under the experimental conditions used for in vitro translation/translocation prompted immediate concern. Aggregation of incompletely folded nascent polypeptide chains can be a thermodynamically favorable process, and is a commonly observed phenomena in in vitro folding studies (51, 53, 54). For this reason, it was important to determine whether the aggregation process observed in the in vitro system occurs co-translationally or post-translationally, and thus whether aggregation could contribute a driving force to translocation. It is clear from recent studies that many precursor proteins form reversible protein-protein aggregates during early stages of protein folding in the ER (44, 45, 51), although to date, co-translational aggregation of nascent chains has not been demonstrated.

To evaluate the structural status of translocation intermediates, a series of stable, truncated translocation intermediates was studied. In these experiments, nascent pPL chains of 86 and 169 amino acids were translated from truncated mRNA transcripts. Such transcripts, because they do not possess a termination codon, direct synthesis of the nascent chain, but remain in stable association with the ribosome (55, 56). As depicted in Fig. 6, panels A and D, greater than 80% of membrane-associated 86-amino acid pPL precursor (pPL 86-mer), either in association with the ribosome (not shown) or upon puromycin-induced release into the ER lumen (+ Puro), was recovered at the top of the sucrose gradients, and thus, by these criteria, does not undergo extensive aggregation. pPL 86-mer, when bound to the ribosome, is not a substrate for the signal peptidase and does not extend into the ER lumen (31, 36, 52). pPL 169-mer, in contrast, is of sufficient length to undergo signal peptide cleavage while remaining in association with the ribosome, and thus has gained access to the ER lumen (34, 57). By comparing the relative migration in sucrose gradients of full-length prolactin, synthesized in vivo (Fig. 4A), with the signal cleaved pPL 169-mer translocation intermediate (Fig. 6, B-D), it is clear that at an early stage of translocation, in vitro translocation nascent chains can enter a heterogeneous aggregate pool. We have so far been unable to identify stable complexes of the translocation intermediates with lumenal chaperones, such as BiP or PDI (data not shown). It thus appears that aggregates are forming with partially folded precursors present in the ER lumen during translocation (see "Discussion"). When pL 169-mer intermediates are released from the ribosome prior to solubilization, aggregation was exacerbated, and the protein was recovered in fractions throughout the gradient (Fig. 6, C and D). As expected from previous results, the FA form of pL 169-mer behaved similarly, although displaying a higher propensity for aggregation (data not shown).


Fig. 6. Analysis of the structural state of preprolactin translocation intermediates. Truncated mRNAs, encoding wild type preprolactin constructs of 86 and 169 amino acids, were translated in reticulocyte lysate in the presence of RM for 30 min at 25 °C. Where indicated, puromycin was added to 0.5 mM and the reaction continued for 5 min at 25 °C. All reactions were subsequently treated with 20 mM NEM and the membrane fraction recovered by centrifugation. Membrane fractions were solubilized in detergent and processed on 8-35% sucrose gradients as described in the legend to Fig. 5. Samples were resolved on 12.5% Tris-Tricine gels and digital images of the dried gels, obtained by PhosphorImager analysis, are depicted. A, WT pPL-86-mer, treated with puromycin; B, WT pPl 169-mer, without puromycin treatment; C, pPL 169-mer following puromycin treatment. D, plot of data depicted in A-C.
[View Larger Version of this Image (67K GIF file)]

Structural State of Nascent Chains in Chaperone-depleted Membranes

The results presented in Figs. 5 and 6 make evident an important point. Although the in vitro translation/translocation system can accurately reproduce the signal cleavage and translocation events that accompany translocation, the structural status of the translocated proteins, be they wild-type or mutant, are significantly different from that observed in vivo. In light of experimental evidence indicating that lumenal proteins support both vectorial translocation and efficient protein folding, the structural state of nascent chains synthesized in the presence of native RM or vesicles depleted of lumenal chaperones was compared. Given the propensity toward aggregation seen in native membranes, we postulated that in the absence of chaperones, aggregation would be exacerbated, and thus might contribute the predominant driving force for translocation. Previously we reported that reconstitution of translocation competent vesicles from detergent-solubilized ER membranes results in the near complete loss of the lumenal contents and a marked reduction in the efficiency with which signal-cleaved precursors are fully transported (39, 58). Similar findings are illustrated in panels A and B of Fig. 7. In comparing native and reconstituted RM, both vesicle populations were observed to efficiently mediate translocation to the point of signal sequence cleavage (Fig. 7A, compare lanes 1, 2, and 5). Protease protection studies, a measure of net translocation, demonstrate, however, that the rRM do not translocate the signal-cleaved precursors as efficiently as RM (Fig. 7A, lanes 2 and 3 versus 5 and 6). This observation is further substantiated in the sedimentation studies detailed in Fig. 7B. In the experiment illustrated in Fig. 7B, membrane fractions were isolated from the completed translation reactions by centrifugation, and the pellet and supernatant samples analyzed for the recovery of associated translation products. In the absence of membranes (Fig. 7B, lanes 1, 2, 5, and 6), the nascent precursor (p) is recovered in the supernatant fraction, whereas in the presence of native membranes, the signal cleaved, or mature form (m) co-sediments with membrane fraction (lanes 3 and 4). In contrast, when translations are performed in the presence of reconstituted membranes, substantial quantities of the signal-cleaved, mature protein are recovered in the supernatant fraction (Fig. 7B, lanes 7 and 8). The recovery of the signal-cleaved form of prolactin in the supernatant fraction indicates that the precursor had undergone targeting and translocation to the point of signal sequence cleavage. A substantial fraction of the signal-cleaved precursor, however, transited free from the translocon to the cytoplasm and was thus recovered in the supernatant. The structural state of the prolactin synthesized in the presence of control and reconstituted membranes was further analyzed be velocity sedimentation (Fig. 7C and D). Consistent with previous results (Fig. 5), pPL-WT, when translated in the presence of RM, is recovered throughout the gradient, with the predominant fraction present at the top of the gradients. When translated in the presence of reconstituted RM, WT-prolactin was preferentially recovered in the aggregate pool, with a distribution markedly similar to that observed for the prolactin-FA folding mutant in vivo (Fig. 4) and in vitro (Fig. 5). In point, when translated in the presence of reconstituted membranes, the translocation behavior and structural state of the WT- and FA-prolactin were very similar, indicating that in the absence of lumenal proteins, the protein folding and translocation pathways are markedly altered from the in vivo state (data not shown).


Fig. 7. Effects of depletion of the lumenal contents of rough microsomes on protein translocation and protein folding. RM were depleted of lumenal proteins by detergent reconstitution, as described under "Materials and Methods." Native (RM) and reconstituted (rRM) membranes were analyzed for translocation activity by protease protection studies (panel A), sedimentation (panel B), and protein folding (panel C). In panel A, wild type, full-length preprolactin was translated in the presence or absence of native and reconstituted membranes and translocation activity assayed as protection from proteolytic degradation (Prot. K) of the signal cleaved, mature prolactin in the absence, but not the presence of detergent (CHAPS). In panel B, wild type, full-length preprolactin was translated in the presence or absence of native and reconstituted membranes and translocation activity assayed by sedimentation assays of membrane association. P, pellet (membrane) fraction; S, supernatant. p and m indicate the precursor and mature forms of the translation product. In panel C, wild type, full-length prolactin was synthesized in the presence or absence of native and reconstituted membranes. Following translation, reactions were alkylated with 20 mM NEM, solubilized by addition of detergent, centrifuged to remove insoluble components, and the supernatant fraction analyzed by velocity sedimentation on 8-35% sucrose gradients. Gels shown in panel C were quantitated by PhosphorImager analysis and the distribution of translation products illustrated in panel D.
[View Larger Version of this Image (45K GIF file)]


DISCUSSION

Substantial progress has been made in identifying the protein components that mediate protein translocation in the mammalian ER. It is, however, presently uncertain how the process is energetically driven. Current models suggest either of two mechanisms. In one model, the direct association of the translationally active ribosome with the protein conducting channel is thought to provide a topologically restricted pathway for the nascent chain such that the nascent chain has no topological alternative other than transfer into the ER lumen, or, in the case of membrane proteins, insertion into the ER bilayer (1, 2). In this model, the random, thermal motion of the nascent chain within the protein conducting channel would serve as the driving force. Alternatively, although not exclusively, protein translocation in the mammalian ER may be energetically driven in a manner similar to that proposed for translocation in yeast ER as well as for protein import into mitochondria (3, 5, 6, 12, 25). In the latter model, the free energy for transport is derived primarily through transient physical interactions of the nascent chain with lumenal, or matrix, molecular chaperones and structural alterations in the nascent chain that accompany translocation in the ER. It has been proposed that such interactions would perform a thermal ratchet function and thereby bias the random motion of the nascent chain to yield vectorial transport (3-5).

Protein folding in the ER occurs coincident with translocation, is accompanied by a significant free energy change, can be readily modified through alterations in the primary protein sequence, and occurs in an environment, the ER lumen, which is highly enriched in molecular chaperones (7, 9-11, 42). It is with these considerations in mind that the effects of a disrupted protein folding pathway on ER translocation were investigated in vivo and in vitro. Protein folding was disrupted through mutagenesis of the folding substrate, as well as by depletion of the ER lumenal chaperones. The folding substrate used was the secretory protein preprolactin, which contains a small, disulfide-bonded loop domain at the immediate NH2 terminus of the mature protein (28). This region of prolactin is the first to be translocated into the ER lumen and necessarily comprises the NH2 terminus of the first folding domain. By disrupting this domain, it was predicted that the folding pathway and interaction with lumenal chaperones and protein folding enzymes would be significantly altered at an early stage of the translocation process.

In in vivo pulse-chase studies, it was observed that the mutant prolactin (FA) rapidly entered an aggregate pool comprised of mixed protein-protein and disulfide bonded complexes, and was neither secreted nor degraded (Fig. 4). Wild type preprolactin, in contrast, was efficiently secreted, with a half-time of 45 min. pPL-FA was efficiently translocated. Following homogenization of the transfected cells, and isolation of the microsomal fraction, prolactin-FA was observed to reside within the microsomal fraction (Fig. 3). From these data we conclude that although the protein folding pathway has been significantly altered, protein translocation proceeds normally. This conclusion is consistent with a number of previous observations and indicates that during passage across the ER membrane the nascent chain remains in an extended, unstructured state and likely does not enter an aggregate pool until having accessed the ER lumen (41, 59-61).

In investigating the energetics of translocation it was considered that protein aggregation, as a thermodynamically favorable process, could contribute a driving force to protein translocation. Indeed, extremely rapid heteroaggregate formation, occurring at or prior to chain termination, has been previously reported in cells synthesizing the Semliki Forest virus proteins E1 and p62 (51). For protein-protein aggregation to directly contribute to the energetics of translocation, however, it must occur co-translationally. Through use of truncated preprolactin precursor proteins synthesized in the presence of canine pancreas rough microsomes it was observed that indeed co-translational aggregation can occur. In these experiments, truncated forms of preprolactin, previously demonstrated to comprise defined translocation intermediates (31, 36, 52, 57), were assembled into rough microsomes and the structural state of the nascent chains subsequently determined by velocity sedimentation of a chemically alkylated, detergent-solubilized extract. Because homotypic, co-translational protein-protein interactions are unlikely to occur (7) (although there may be exceptions to this postulate (62)), it is most likely that the aggregate state observed for the truncated prolactin intermediates reflects interactions of the newly synthesized nascent chains with lumenal proteins, and/or partially folded or incompletely assembled native proteins which would remain in the microsomal vesicle lumen during tissue isolation and membrane preparation. That we have as yet been unable to identify substantial interactions with the ER lumenal proteins suggests that the latter possibility is likely.

Two additional noteworthy observations were obtained in the in vitro system. In studies with the full-length WT and FA translation products, it was observed that translocation proceeded normally, however, a significant fraction of the WT, and the majority of the FA form of prolactin, were recovered as large, heterogeneous aggregates. Thus, although the FA folding defect could be reproduced in vitro, it was also clear that in vitro the WT protein underwent substantial misfolding. Second, in lumenal protein-depleted membranes, the efficiency of translocation and folding were markedly reduced (Fig. 7). As previously reported, the loss of the lumenal chaperones had little effect on the efficiency of the early stages of translocation, i.e. translocation up to and including signal sequence cleavage (12, 58). When translated in the presence of rough microsomes lacking lumenal proteins, the vast majority of the signal-cleaved WT translation products were present as large aggregates. The observation that aggregated, signal-cleaved prolactin could be recovered in the supernatant fraction following sedimentation of the membranes indicates that a significant fraction of the prolactin underwent retrograde transport from the translocon and subsequent aggregation. It should also be noted that the structural state of WT prolactin, synthesized in the lumenal protein-depleted membranes, was remarkably similar to that of the folding mutant, FA, synthesized in the presence of native membranes. These data suggest that the lumenal proteins likely perform two functions: (i) through interactions with the nascent chain early in translocation, lumenal proteins may support unidirectional transport and (ii) interactions of the lumenal chaperones with the nascent chains suppress irreversible aggregation reactions and enhance the efficiency of protein folding.

The data presented herein have significant ramifications on investigations into the molecular mechanism of protein translocation. To accurately identify the molecular basis of translocation, it is critical that the experimental system accurately mimic the in vivo scenario. In many regards, the in vitro translation/translocation systems admirably achieves this goal. Analysis of the structural state of the nascent chains indicates, however, that in vitro, translocated proteins may undergo highly aberrant folding processes and accumulate as protein-protein and disulfide-bonded aggregates. Furthermore, such disruptions in protein folding are exacerbated under conditions, such as detergent reconstitution, in which the lumenal complement of chaperones and protein folding enzymes are lost. This is especially problematic for studies of the energetic basis of translocation for which direct roles for lumenal proteins in translocation have been identified or implicated. On the basis of these data, we suggest that the criteria for accurate protein translocation be extended to include proper protein folding and/or assembly.


FOOTNOTES

*   This work was supported by National Institutes of Health Grant DK47897.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Current address: Dept. of Biochemistry, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157.
§   To whom correspondence should be addressed. Tel.: 919-684-8948; Fax: 919-684-5481; E-mail: C.Nicchitta{at}cellbio.duke.edu.
1   The abbreviations used are: ER, endoplasmic reticulum; RM, rough microsomes; WT, wild type, FA, folding mutant; BiP, immunoglobulin heavy chain-binding protein; pPL, preprolactin; PCR, polymerase chain reaction; PBS, phosphate-buffered saline; DTT, dithiothreitol; PAGE, polyacrylamide gel electrophoresis; CHAPS, 3-[3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; NEM, N-ethylmaleimide.
2   R. L. Haynes and C. V. Nicchitta, unpublished observations.

ACKNOWLEDGEMENTS

We thank Edwin Murphy, Matthew Potter, and Pamela Wearsch for helpful comments and criticism of the manuscript.


REFERENCES

  1. Walter, P., and Johnson, A. E. (1994) Annu. Rev. Cell Biol. 10, 87-119 [CrossRef]
  2. Rapoport, T. A., Jungnickel, B., and Katay, U. (1996) Annu. Rev. Biochem. 65, 271-303 [CrossRef][Medline] [Order article via Infotrieve]
  3. Neupert, W., Hartl, F.-U., Craig, E. A., and Pfanner, N. (1990) Cell 63, 447-450 [Medline] [Order article via Infotrieve]
  4. Simon, S. M., Peskin, C. S., and Oster, G. F. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3770-3774 [Abstract]
  5. Nicchitta, C. V., and Blobel, G. (1993) Cell 73, 989-998 [Medline] [Order article via Infotrieve]
  6. Sanders, S. L., Whitfield, K. M., Vogel, J. P., Rose, M. D., and Schekman, R. W. (1992) Cell 69, 353-365 [Medline] [Order article via Infotrieve]
  7. Hurtley, S. M., and Helenius, A. (1989) Annu. Rev. Cell Biol. 5, 277-307 [CrossRef]
  8. Hwang, C., Sinskey, A. J., and Lodish, H. F. (1992) Science 257, 1496-1502 [Medline] [Order article via Infotrieve]
  9. Helenius, A. (1994) Mol. Biol. Cell. 5, 253-265 [Medline] [Order article via Infotrieve]
  10. Rothman, J. E. (1989) Cell 59, 591-601 [Medline] [Order article via Infotrieve]
  11. Gething, M.-J., and Sambrook, J. (1992) Nature 355, 33-47 [CrossRef][Medline] [Order article via Infotrieve]
  12. Nicchitta, C. V. (1996) Semin. Cell. Dev. Biol. 7, 497-503 [CrossRef]
  13. Görlich, D., and Rapoport, T. A. (1993) Cell 75, 615-630 [Medline] [Order article via Infotrieve]
  14. Oliver, J., Jungnickel, B., Görlich, D., Rapoport, T., and High, S. (1995) FEBS Lett. 362, 126-130 [CrossRef][Medline] [Order article via Infotrieve]
  15. Kalies, K. U., Gorlich, D., and Rapoport, T. A. (1994) J. Cell Biol. 126, 925-934 [Abstract]
  16. Crowley, K. S., Reinhart, G. D., and Johnson, A. E. (1993) Cell 73, 1101-1115 [Medline] [Order article via Infotrieve]
  17. Vogel, J. P., Misra, L. M., and Rose, M. D. (1990) J. Cell Biol. 110, 1885-1895 [Abstract]
  18. Nguyen, T. H., Law, D. T., and Williams, D. B. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1565-1569 [Abstract]
  19. Brodsky, J. L., and Schekman, R. (1993) J. Cell Biol. 123, 1355-1363 [Abstract]
  20. Panzner, S., Dreier, L., Hartmann, E., Kostka, S., and Rapoport, T. A. (1995) Cell 81, 561-570 [Medline] [Order article via Infotrieve]
  21. Gambill, B. D., Voos, W., Kang, P. J., Miao, B., Langer, T., Craig, E. A., and Pfanner, N. (1993) J. Cell Biol. 123, 109-117 [Abstract]
  22. Berthold, J., Bauer, M. F., Schneider, H.-C., Klaus, C., Dietmeier, K., Neupert, W., and Brunner, M. (1995) Cell 81, 1085-1093 [Medline] [Order article via Infotrieve]
  23. Horst, M., Oppliger, W., Feifel, B., Schatz, G., and Glick, B. S. (1996) Protein Sci. 5, 759-767 [Abstract/Free Full Text]
  24. Glick, B. S. (1995) Cell 80, 11-14 [Medline] [Order article via Infotrieve]
  25. Brodsky, J. L., Goeckler, J., and Schekman, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9643-9646 [Abstract]
  26. Lyman, S. K., and Schekman, R. (1995) J. Cell Biol. 131, 1163-1171 [Abstract]
  27. Nicoll, C. S., Mayer, G. L., and Russell, S. M. (1986) Endocr. Rev. 7, 169-203 [Medline] [Order article via Infotrieve]
  28. Doneen, B. A., Bewley, T. A., and Li, C. H. (1979) Biochemistry 18, 4851-4860 [Medline] [Order article via Infotrieve]
  29. Gluzman, Y. (1981) Cell 23, 175-182 [Medline] [Order article via Infotrieve]
  30. Gaut, J. R., and Hendershot, L. M. (1993) J. Biol. Chem. 268, 7248-7255 [Abstract/Free Full Text]
  31. Connolly, T., and Gilmore, R. (1986) J. Cell Biol. 103, 2253-2261 [Abstract]
  32. Higuchi, R. (1989) PCR Techniques, pp. 61-70, Stockton Press, NY
  33. Dorner, A. J., and Kaufman, R. J. (1990) Methods Enzymol. 185, 577-596 [Medline] [Order article via Infotrieve]
  34. Nicchitta, C. V., Murphy, E. C., Haynes, R., and Shelness, G. S. (1995) J. Cell Biol. 129, 957-970 [Abstract]
  35. Braakman, I., Helenius, J., and Helenius, A. (1992) Nature 356, 260-262 [CrossRef][Medline] [Order article via Infotrieve]
  36. Nicchitta, C. V., and Blobel, G. (1989) J. Cell Biol. 108, 789-795 [Abstract]
  37. Jackson, R. J., and Hunt, T. (1983) Meth. Enzymol. 96, 50-73 [Medline] [Order article via Infotrieve]
  38. Walter, P., and Blobel, G. (1983) Methods Enzymol. 96, 84-93 [Medline] [Order article via Infotrieve]
  39. Nicchitta, C., Migliaccio, G., and Blobel, G. (1991) Methods Cell Biol. 34, 263-285 [Medline] [Order article via Infotrieve]
  40. Abdel-Meguid, S. S., Shieh, H.-S., Smith, W. W., Dayringer, H. E., Violand, B. N., and Bentle, L. A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6434-6437 [Abstract]
  41. Bergman, L. W., and Kuehl, W. M. (1979) J. Biol. Chem. 254, 8869-8876 [Medline] [Order article via Infotrieve]
  42. Pelham, H. R. B. (1989) Ann. Rev. Cell Biol. 5, 1-23 [CrossRef]
  43. Lodish, H. F., Kong, N., Snider, M., and Strous, G. J. A. M. (1983) Nature 304, 80-83 [Medline] [Order article via Infotrieve]
  44. de Silva, A., Braakman, I., and Helenius, A. (1993) J. Cell Biol. 120, 647-655 [Abstract]
  45. Kim, P. S., Bole, D., and Arvan, P. (1992) J. Cell Biol. 118, 541-549 [Abstract]
  46. Klausner, R. D., and Sitia, R. (1990) Cell 62, 611-614 [Medline] [Order article via Infotrieve]
  47. Lord, J. M. (1996) Curr. Biol. 6, 1067-1069 [Medline] [Order article via Infotrieve]
  48. Werner, E. D., Brodsky, J. L., and McCracken, A. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13797-13801 [Abstract/Free Full Text]
  49. Qu, D., Teckman, J. H., Omura, S., and Perlmutter, D. H. (1996) J. Biol. Chem. 271, 22791-22795 [Abstract/Free Full Text]
  50. Hiller, M. M., Finger, A., Schweiger, M., and Wolf, D. H. (1996) Science 273, 1725-1728 [Abstract/Free Full Text]
  51. Marquardt, T., and Helenius, A. (1992) J Cell Biol 117, 505-513 [Abstract]
  52. Jungnickel, B., and Rapoport, T. A. (1995) Cell 82, 261-270 [Medline] [Order article via Infotrieve]
  53. Jaenicke, R. (1987) Prog. Biophys. Mol. Biol. 49, 117-237 [CrossRef][Medline] [Order article via Infotrieve]
  54. Bonnerot, C., Marks, M. S., Cosson, P., Robertson, E. J., Bikoff, E. K., and Germain, R. N. (1994) EMBO J. 13, 934-944 [Abstract]
  55. Gilmore, R., Collins, P., Johnson, J., Kellaris, K., and Rapiejko, P. (1991) Methods Cell Biol 34, 223-239 [Medline] [Order article via Infotrieve]
  56. Perara, E., Rothman, R., and Lingappa, V. (1986) Science 232, 348-352 [Medline] [Order article via Infotrieve]
  57. Connolly, T., Collins, P., and Gilmore, R. (1989) J. Cell Biol. 108, 299-307 [Abstract]
  58. Nicchitta, C. V., and Blobel, G. (1990) Cell 60, 259-269 [Medline] [Order article via Infotrieve]
  59. Gething, M.-J., McCannon, K., and Sambrook, J. (1986) Cell 46, 939-950 [Medline] [Order article via Infotrieve]
  60. Machamer, C. E., and Rose, J. K. (1988) J. Biol. Chem. 263, 5955-5960 [Abstract/Free Full Text]
  61. Valetti, C., Brossi, C. E., Milstein, C., and Sitia, R. (1991) J. Cell Biol. 4, 983-994
  62. Redick, S. D., and Schwarzbauer, J. E. (1995) J. Cell Sci. 108, 1761-1769 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.